Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 45

Sort by

Sort Order Select

Journal Articles

A Phase 2B, Open-Label Multicenter Study of Tebapivat (AG-946), a Potent Pyruvate Kinase Activator, in Patients with Anemia Due to Lower-Risk Myelodysplastic Syndromes

Amer M. Zeidan, Mikkael A. Sekeres, Hanny Al-Samkari, Hetty E. Carraway, Amy E. DeZern, Moshe Mittelman, Meredith Little, Vanessa Beynon, Xiaoshu Dai, Sal Sommakia, Jenny M. Despotovic, Parija Patel, Melissa Dibacco, Bruno Fattizzo, Eytan M. Stein, David Sallman, Austin G. Kulasekararaj, Uwe Platzbecker, Pierre Fenaux

Blood (2024) 144 (Supplement 1): 6708.

https://doi.org/10.1182/blood-2024-203073

Published: 2024

Journal Articles

A Phase 3 Study of Eltrombopag Vs. Standard First-Line Management for Newly Diagnosed Immune Thrombocytopenia in Children: Trial in Progress Update

Blood (2023) 142 (Supplement 1): 1223.

https://doi.org/10.1182/blood-2023-172819

Published: 2023

Journal Articles

Genetic Variants in Canonical Wnt Signaling Pathway Associated with Pediatric ITP

Taylor Olmsted Kim, Jennifer M. Geris, Amanda B. Grimes, Rachael F. Grace, Michele P. Lambert, Melissa J. Rose, Kristin A. Shimano, Omar Niss, Cindy Neunert, Taizo A. Nakano, Derek Macmath, Bogdan Dinu, Susan E. Kirk, Jenny M. Despotovic, Jonathan M. Flanagan, Michael E. Scheurer

Blood (2023) 142 (Supplement 1): 2593.

https://doi.org/10.1182/blood-2023-175013

Published: 2023

Journal Articles

Outcomes of hematopoietic stem cell gene therapy for Wiskott-Aldrich syndrome

Blood (2023) 142 (15): 1281–1296.

https://doi.org/10.1182/blood.2022019117

Published: 2023

Includes: Supplemental data

Journal Articles

Immune cells surveil aberrantly sialylated O -glycans on megakaryocytes to regulate platelet count

Melissa M. Lee-Sundlov, Robert T. Burns, Taylor O. Kim, Renata Grozovsky, Silvia Giannini, Leonardo Rivadeneyra, Yongwei Zheng, Simon H. Glabere, Walter H. A. Kahr, Reza Abdi, Jenny M. Despotovic, Demin Wang, Karin M. Hoffmeister

Blood (2021) 138 (23): 2408–2424.

https://doi.org/10.1182/blood.2020008238

Published: 2021

Includes: Multimedia, Supplemental data

Journal Articles

Immature Platelet Fraction Does Not Correlate with Treatment Response in Immune Thrombocytopenia

Emily M. Harris, Michele P. Lambert, Jenny M. Despotovic, Susan E Kirk, Abinaya Arulselvan, Matthew Basara, Brenna Cannon, Sam King, David N Williams, Rachael F. Grace

Blood (2021) 138 (Supplement 1): 1024.

https://doi.org/10.1182/blood-2021-151681

Published: 2021

Journal Articles

Predicting Chronic Immune Thrombocytopenia in Pediatric Patients at Disease Presentation: Leveraging Clinical and Laboratory Characteristics Via Machine Learning Models

Taylor Olmsted Kim, Derek MacMath, Rowland W Pettit, Susan E Kirk, Amanda B Grimes, Megan M Gilbert, Jacquelyn M. Powers, Jenny M. Despotovic

Blood (2021) 138 (Supplement 1): 1023.

https://doi.org/10.1182/blood-2021-153989

Published: 2021

Journal Articles

An Analysis of Immature Platelet Fraction Values

Cicely Conway, Amanda B Grimes, Jenny M. Despotovic, Susan E Kirk, Taylor Olmsted Kim, Xiaofan Huang, Charles Minard

Blood (2021) 138 (Supplement 1): 3171.

https://doi.org/10.1182/blood-2021-151956

Published: 2021

Journal Articles

Premedication with Hydrocortisone Increases Risk of Adverse Drug Events and Return to Medical Care Among Pediatric Patients with ITP Treated with IVIG

Megan M Gilbert, Taylor Olmsted Kim, Susan E Kirk, Hyojeong Han, Xiaofan Huang, Kristen A Staggers, Rachael F. Grace, Cindy Neunert, Michele P. Lambert, Jenny M. Despotovic, Amanda B Grimes

Blood (2021) 138 (Supplement 1): 1917.

https://doi.org/10.1182/blood-2021-153385

Published: 2021

Journal Articles

Tapering Thrombopoietin Receptor Agonists in Primary Immune Thrombocytopenia: Recommendations Based on the RAND/UCLA Modified Delphi Panel Method

Adam Cuker, MD, Jenny M. Despotovic, DO, Rachael F. Grace, MD, Caroline Kruse, Michele P. Lambert, MD MSTR, Howard Liebman, MD, Roger M. Lyons, MD, Keith R McCrae, MD, Vinod A. Pullarkat, MD, Jeffrey Wasser, MD, David Beenhouwer, MD, Sarah N Gibbs, MPH, Irina Yermilov, MD MPH, MS, Michael S Broder, MD MSHS

Blood (2020) 136 (Supplement 1): 6–8.

https://doi.org/10.1182/blood-2020-133262

Published: 2020

Journal Articles

Racial variation in ITP prevalence and chronic disease phenotype suggests biological differences

Taylor Olmsted Kim, Amanda B. Grimes, Susan E. Kirk, Megan M. Gilbert, Helen D. Reed, Kristen A. Staggers, Lauryn A. Walker, Abinaya Arulselvan, A. Sarah Cohen, Michele P. Lambert, Jenny M. Despotovic

Blood (2020) 136 (5): 640–643.

https://doi.org/10.1182/blood.2020004888

Published: 2020

Includes: Supplemental data

Journal Articles

Characterization of the Severe Phenotype of Pyruvate Kinase Deficiency

Blood (2019) 134 (Supplement_1): 949.

https://doi.org/10.1182/blood-2019-125352

Published: 2019

Journal Articles

Novel HLA Typing Method Identifies HLA Alleles Associated with Pediatric ITP

Taylor Olmsted Kim, MD, Michael Greenwood, MD, Todd Eagar, PhD, Jenny M. Despotovic, DO, MS

Blood (2019) 134 (Supplement_1): 1067.

https://doi.org/10.1182/blood-2019-129235

Published: 2019

Journal Articles

Updated Results from the Single-Arm, Open-Label, Long-Term Efficacy and Safety Study of Subcutaneous (SC) Romiplostim in Children with Immune Thrombocytopenia (ITP)

John Grainger, MD MRCP, FRPATH, James B. Bussel, MD, Michael D. Tarantino, MD, Nichola Cooper, Donald Beam, Jenny M. Despotovic, DO, Alexey A. Maschan, MD, Kejia Wang, PhD, Melissa Jeanne Eisen, MD, Charles Bowers, MD

Blood (2019) 134 (Supplement_1): 1095.

https://doi.org/10.1182/blood-2019-131241

Published: 2019

Journal Articles

Comorbidities and Complications in Adults with Pyruvate Kinase Deficiency

Blood (2019) 134 (Supplement_1): 2175.

https://doi.org/10.1182/blood-2019-123069

Published: 2019

Journal Articles

Immunoglobulin Levels As Predictors of the Development of Chronic Disease in Pediatric Immune Thrombocytopenia

Amanda Bell Grimes, MD, Taylor Olmsted Kim, MD, Jenny M. Despotovic, DO, MS, Susan Kirk, PA-C

Blood (2019) 134 (Supplement_1): 388.

https://doi.org/10.1182/blood-2019-132285

Published: 2019

Journal Articles

Racial Variation in ITP Prevalence and Rate of Chronic Disease Suggests Biological Differences

Lauryn S. Walker, Taylor Olmsted Kim, MD, Amanda Bell Grimes, MD, Susan Kirk, PA-C, Audrey S. Cohen, Abinaya Arulselvan, Scott E. Wenderfer, MD, Michele P. Lambert, MD, Jenny M. Despotovic, DO, MS

Blood (2019) 134 (Supplement_1): 387.

https://doi.org/10.1182/blood-2019-130418

Published: 2019

Journal Articles

A Phase 3 Study of Eltrombopag Vs. Standard First-Line Management for Newly Diagnosed Immune Thrombocytopenia in Children

Kristin A. Shimano, MD, Rachael F. Grace, MD, Carolyn M. Bennett, MDMSc, Robert J Klaassen, MD FRCPC, Cindy Neunert, MD, Ellis J. Neufeld, MD, Clement Ma, PhD, Wendy B. London, PhD, Jenny M. Despotovic, DO, MS

Blood (2019) 134 (Supplement_1): 2369.

https://doi.org/10.1182/blood-2019-125487

Published: 2019

Journal Articles

Outcome of Hematopoietic Stem Cell Gene Therapy for Wiskott-Aldrich Syndrome

Blood (2019) 134 (Supplement_1): 4629.

https://doi.org/10.1182/blood-2019-126161

Published: 2019

Journal Articles

Targeting Immune Dysregulation in Childhood Evans Syndrome

Amanda Bell Grimes, MD, Taylor Kim, MD, Susan E. Kirk, PA-C, Michele P. Lambert, MD, Rachael F. Grace, MD, Jenny M. Despotovic, DO, MS

Blood (2018) 132 (Supplement 1): 3564.

https://doi.org/10.1182/blood-2018-99-110734

Published: 2018

NARROW

A Phase 2B, Open-Label Multicenter Study of Tebapivat (AG-946), a Potent Pyruvate Kinase Activator, in Patients with Anemia Due to Lower-Risk Myelodysplastic Syndromes

A Phase 3 Study of Eltrombopag Vs. Standard First-Line Management for Newly Diagnosed Immune Thrombocytopenia in Children: Trial in Progress Update

Genetic Variants in Canonical Wnt Signaling Pathway Associated with Pediatric ITP

Outcomes of hematopoietic stem cell gene therapy for Wiskott-Aldrich syndrome

Immune cells surveil aberrantly sialylated O -glycans on megakaryocytes to regulate platelet count

Immature Platelet Fraction Does Not Correlate with Treatment Response in Immune Thrombocytopenia

Predicting Chronic Immune Thrombocytopenia in Pediatric Patients at Disease Presentation: Leveraging Clinical and Laboratory Characteristics Via Machine Learning Models

An Analysis of Immature Platelet Fraction Values

Premedication with Hydrocortisone Increases Risk of Adverse Drug Events and Return to Medical Care Among Pediatric Patients with ITP Treated with IVIG

Tapering Thrombopoietin Receptor Agonists in Primary Immune Thrombocytopenia: Recommendations Based on the RAND/UCLA Modified Delphi Panel Method

Racial variation in ITP prevalence and chronic disease phenotype suggests biological differences

Characterization of the Severe Phenotype of Pyruvate Kinase Deficiency

Novel HLA Typing Method Identifies HLA Alleles Associated with Pediatric ITP

Updated Results from the Single-Arm, Open-Label, Long-Term Efficacy and Safety Study of Subcutaneous (SC) Romiplostim in Children with Immune Thrombocytopenia (ITP)

Comorbidities and Complications in Adults with Pyruvate Kinase Deficiency

Immunoglobulin Levels As Predictors of the Development of Chronic Disease in Pediatric Immune Thrombocytopenia

Racial Variation in ITP Prevalence and Rate of Chronic Disease Suggests Biological Differences

A Phase 3 Study of Eltrombopag Vs. Standard First-Line Management for Newly Diagnosed Immune Thrombocytopenia in Children

Outcome of Hematopoietic Stem Cell Gene Therapy for Wiskott-Aldrich Syndrome

Targeting Immune Dysregulation in Childhood Evans Syndrome

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only